Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8309690 Integrated approach for generating multidomain protein therapeutics

Patent 8309690 was granted and assigned to MedImmune on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

MedImmune

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8309690

Date of Patent

November 13, 2012

Patent Application Number

11993680

Date Filed

June 30, 2006

Patent Citations Received

‌

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

‌

US Patent 11932675 PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties

‌

US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens

‌

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

‌

US Patent 11840579 Bispecific antibodies that bind to CD38 and CD3

‌

US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3

‌

US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

...

Patent Primary Examiner

‌

Laura B Goddard

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8309690 Integrated approach for generating multidomain protein therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API